Development of algorithms for a quantitative real time-PCR assay to determine EGFRvIII status in glioblastoma patients from rindopepimut clinical trials.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: LabCorp (United States), Celldex Therapeutics (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2597670751
